WO1998051363A1 - Spray forming device - Google Patents
Spray forming device Download PDFInfo
- Publication number
- WO1998051363A1 WO1998051363A1 PCT/GB1998/001341 GB9801341W WO9851363A1 WO 1998051363 A1 WO1998051363 A1 WO 1998051363A1 GB 9801341 W GB9801341 W GB 9801341W WO 9851363 A1 WO9851363 A1 WO 9851363A1
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- agent
- port means
- mixing chamber
- carrier gas
- spray
- Prior art date
Links
- 238000009718 spray deposition Methods 0.000 title claims abstract description 22
- 239000003795 chemical substances by application Substances 0.000 claims abstract description 49
- 239000012159 carrier gas Substances 0.000 claims abstract description 24
- 239000003814 drug Substances 0.000 claims abstract description 4
- 229940079593 drug Drugs 0.000 claims abstract description 4
- 239000007789 gas Substances 0.000 claims description 16
- 239000007921 spray Substances 0.000 claims description 15
- 238000000034 method Methods 0.000 claims description 8
- 230000003444 anaesthetic effect Effects 0.000 claims description 4
- QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical compound [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 claims description 4
- 239000001301 oxygen Substances 0.000 claims description 4
- 229910052760 oxygen Inorganic materials 0.000 claims description 4
- 239000007788 liquid Substances 0.000 abstract description 2
- 239000000243 solution Substances 0.000 description 6
- 239000000203 mixture Substances 0.000 description 4
- 206010011409 Cross infection Diseases 0.000 description 3
- 206010029803 Nosocomial infection Diseases 0.000 description 3
- 239000012530 fluid Substances 0.000 description 2
- 229940124326 anaesthetic agent Drugs 0.000 description 1
- 238000002347 injection Methods 0.000 description 1
- 239000007924 injection Substances 0.000 description 1
- 238000001990 intravenous administration Methods 0.000 description 1
- 238000009877 rendering Methods 0.000 description 1
- 239000012086 standard solution Substances 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M11/00—Sprayers or atomisers specially adapted for therapeutic purposes
- A61M11/02—Sprayers or atomisers specially adapted for therapeutic purposes operated by air or other gas pressure applied to the liquid or other product to be sprayed or atomised
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M16/00—Devices for influencing the respiratory system of patients by gas treatment, e.g. ventilators; Tracheal tubes
- A61M16/04—Tracheal tubes
- A61M16/0463—Tracheal tubes combined with suction tubes, catheters or the like; Outside connections
Definitions
- the present invention relates to a spray forming device.
- a number of devices for administering drugs to patients in the form of sprays are known, for example, pressurised spray bottles.
- a spray forming device for producing a spray in the form of an atomised agent dispersed within a carrier gas, the device comprising a mixing chamber having a releasable gas port means for attachment to a supply of pressurised carrier gas; a releasable agent port means for attachment to a supply of the agent to be dispersed; and an outlet nozzle.
- the agent is preferably in the form of a liquid.
- such a device When in use, such a device preferably forms a part of a complete spray application system which further includes a means for supplying agent to the device, which means is connected to the device via the agent port means, and a source of pressurised carrier gas, which source is connected to the device via the gas port means.
- the spray forming device of the present invention may be disposed of separately from the source of pressurised carrier gas and the means for supplying agent to the device.
- the spray forming device further comprises a one-way valve associated with the agent port means, which valve acts to prevent the flow of gas from the mixing chamber towards the supply of agent via the agent port means.
- the valve takes the form of a flexible sleeve mounted in the mixing chamber such that a part of its outer surface lies against, and thus closes, an inlet from the agent port means.
- a one-way valve in this manner has the advantage of enabling a very simple unit, such as a common syringe, to be used as the means for supplying agent to the device.
- a unit such as a syringe as the means for supplying agent to the device gives rise to the significant advantage that a physician using the device has complete control over the composition of the agent and exactly how much is administered to the patient.
- the device may be used with any desired solution or mixture of solutions.
- the use of a unit such as a syringe also has the advantage of rendering the operation of the spray forming device very straightforward such that no great manual dexterity is required on the part of an operator.
- the nozzle is elongate having a length of between 0.5cm and 10cm and an internal diameter of between 0.1 mm and 5mm. Such a nozzle gives rise to a fine, well directed spray from the nozzle tip regardless of the skill of the operator of the device.
- a method of forming a spray in the form of an atomised agent dispersed within a carrier gas comprising the steps of providing a device comprising a mixing chamber having a releasable gas port means, a releasable agent port means and an outlet nozzle; releasably attaching a pressurised source of carrier gas to the gas port means; releasably attaching a means for supplying agent to the device, to the agent port means; and simultaneously supplying carrier gas and agent to the mixing chamber via the first and second inlets respectively.
- the carrier gas used is preferably a respirable gas such as medical oxygen or air and is preferably supplied to the mixing chamber at a rate of 1 to 2 litres per minute.
- the advantage of such an arrangement is that the spray application system may be operated in synchrony with the patient's inspiration.
- the agent is typically a drug, anaesthetic or similar for administration to a patient or animal.
- the device may be used to administer both local and general anaesthetics.
- Figure 2 is a cross sectional side view of the spray forming device of Figure 1 .
- the spray forming device 10 comprises a housing 11 within which is formed a mixing chamber 12 having a first inlet 14 and an associated releasable gas port means 15 for attachment to a supply (not shown) of pressurised carrier gas such as medical oxygen or air.
- the carrier gas flows into the mixing chamber 12 in the direction indicated by arrow A1 in Figure 2.
- a second inlet 24 to the mixing chamber 12 has an associated releasable agent port means 25 for attachment to a supply (not shown) of agent.
- An O-ring valve 30 is formed at the second inlet 24 and acts to allow flow through the valve only in the direction indicated by arrow A2 in Figure 2.
- the O-ring valve 30 essentially comprises a flexible cylinder (for example one made of rubber), which, because of its position in front of the inlet 24, prevents the flow of fluid past the valve 30 into the inlet 24. None- the-less, when pressure is applied from the inlet 24, the cylinder deforms inwardly sufficiently to permit the flow of fluid from the inlet 24 to the mixing chamber 12 between the housing 11 and the outer surface of the valve 30.
- the nozzle 40 extends away from the mixing chamber 12 and is preferably formed integrally with the housing 11.
- the nozzle is preferably elongate, as shown, having a length of between 0.5cm and 10cm and an internal diameter of between 0.1mm and 5mm.
- the device 10 shown in Figures 1 and 2 is formed from a conventional narrow gauge intravenous cannula with an injection port 25 (e.g. 20 or 22G Venflon®).
- an injection port 25 e.g. 20 or 22G Venflon®
- the device could, of course, be custom made which would reduce costs.
- a carrier gas in the form of medical air or oxygen is supplied from a pressurised canister thereof (not shown) to the device 10 via medical "green bubble tubing" (not shown) which is releasably attached to the gas port means 15.
- a syringe or part thereof may be releasably attached to the gas port means 15, and the tubing may be releasably attached to the syringe.
- the gas is supplied to the device 10 at a rate of about 1 to 2 litres per minute.
- a syringe (not shown) containing an agent (e.g. anaesthetic) in the form of a solution or mixture of solutions, is releasably attached to the agent port means 25.
- agent e.g. anaesthetic
- the agent is injected around the valve 30 into the mixing chamber 12. Meanwhile, the flow of the pressurised carrier gas through the centre of the valve 30 causes the carrier gas at the downstream side of valve to be turbulent. As a result of the turbulence the agent is essentially atomised and substantially evenly dispersed throughout the carrier gas.
- the spray thus formed travels along the nozzle 40 to its tip, from which it emerges as a fine, well directed spray.
- the device When all of the required agent has been administered, the device
Landscapes
- Health & Medical Sciences (AREA)
- Heart & Thoracic Surgery (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- Anesthesiology (AREA)
- Biomedical Technology (AREA)
- Pulmonology (AREA)
- Hematology (AREA)
- Veterinary Medicine (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Emergency Medicine (AREA)
- Nozzles (AREA)
- Infusion, Injection, And Reservoir Apparatuses (AREA)
Abstract
A spray forming device primarily intended for administering drugs to patients, said device comprising a mixing chamber (12) having an inlet (14) for carrier gas and an inlet (24) for (usually liquid) agents. A one-way valve in the form of a cylindrical sleeve (30) of rubber is formed in the mixing chamber (12) and normally covers the inlet (24). Supply of agent, for example, from a syringe is of sufficient pressure to deform the sleeve (30) to allow the agent into the mixing chamber (12) where it is atomised within the carrier gas and dispensed through a nozzle (40).
Description
"SPRAY FORMING DEVICE"
The present invention relates to a spray forming device. A number of devices for administering drugs to patients in the form of sprays are known, for example, pressurised spray bottles. There are, however, a number of disadvantages associated with currently available spray forming devices.
One disadvantage of such devices is that they are generally sold as complete spray application systems formed as units which already incorporate a particular single agent solution which may not subsequently be altered. Thus it is not possible for a physician to customise currently available spray forming devices to administer a non-standard solution or mixture of solutions. Furthermore, such devices are not intended to be disposed of after each use. This gives rise to a risk of cross-infection between patients exposed to the devices.
According to a first aspect of the present invention, there is provided a spray forming device for producing a spray in the form of an atomised agent dispersed within a carrier gas, the device comprising a mixing chamber having a releasable gas port means for attachment to a supply of pressurised carrier gas; a releasable agent port means for attachment to a supply of the agent to be dispersed; and an outlet nozzle. The agent is preferably in the form of a liquid. When in use, such a device preferably forms a part of a complete spray application system which further includes a means for supplying agent to the device, which means is connected to the device via the agent port means, and a source of pressurised carrier gas, which source is connected to the device via the gas port means.
Such a system has a significant advantage over known spray application systems which is that the spray forming device of the present invention may be disposed of separately from the source of pressurised
carrier gas and the means for supplying agent to the device. Thus that part of the system which is likely to come into contact with patients may be economically disposed of after each use of the system. This eliminates the risk of cross-infection between patients. Preferably, the spray forming device further comprises a one-way valve associated with the agent port means, which valve acts to prevent the flow of gas from the mixing chamber towards the supply of agent via the agent port means. Preferably the valve takes the form of a flexible sleeve mounted in the mixing chamber such that a part of its outer surface lies against, and thus closes, an inlet from the agent port means. The use of a one-way valve in this manner has the advantage of enabling a very simple unit, such as a common syringe, to be used as the means for supplying agent to the device. The use of a unit such as a syringe as the means for supplying agent to the device gives rise to the significant advantage that a physician using the device has complete control over the composition of the agent and exactly how much is administered to the patient. Thus the device may be used with any desired solution or mixture of solutions.
The use of a unit such as a syringe also has the advantage of rendering the operation of the spray forming device very straightforward such that no great manual dexterity is required on the part of an operator. Preferably the nozzle is elongate having a length of between 0.5cm and 10cm and an internal diameter of between 0.1 mm and 5mm. Such a nozzle gives rise to a fine, well directed spray from the nozzle tip regardless of the skill of the operator of the device.
According to a second aspect of the present invention, there is provided a method of forming a spray in the form of an atomised agent dispersed within a carrier gas, the method comprising the steps of providing a device comprising a mixing chamber having a releasable gas port means, a releasable agent port means and an outlet nozzle;
releasably attaching a pressurised source of carrier gas to the gas port means; releasably attaching a means for supplying agent to the device, to the agent port means; and simultaneously supplying carrier gas and agent to the mixing chamber via the first and second inlets respectively. The carrier gas used is preferably a respirable gas such as medical oxygen or air and is preferably supplied to the mixing chamber at a rate of 1 to 2 litres per minute. The advantage of such an arrangement is that the spray application system may be operated in synchrony with the patient's inspiration. The agent is typically a drug, anaesthetic or similar for administration to a patient or animal. The device may be used to administer both local and general anaesthetics.
In order that the present invention may be better understood an embodiment thereof will now be described by way of example only and with reference to the accompanying drawings in which:- Figure 1 is a partially cross sectional diagrammatic view from below of a spray forming device according to the present invention; and
Figure 2 is a cross sectional side view of the spray forming device of Figure 1 .
The spray forming device 10 comprises a housing 11 within which is formed a mixing chamber 12 having a first inlet 14 and an associated releasable gas port means 15 for attachment to a supply (not shown) of pressurised carrier gas such as medical oxygen or air. The carrier gas flows into the mixing chamber 12 in the direction indicated by arrow A1 in Figure 2. A second inlet 24 to the mixing chamber 12 has an associated releasable agent port means 25 for attachment to a supply (not shown) of agent. An O-ring valve 30 is formed at the second inlet 24 and acts to allow flow through the valve only in the direction indicated by arrow A2 in Figure 2. The O-ring valve 30 essentially comprises a flexible cylinder (for example one made of rubber), which, because of its position in front of the inlet 24, prevents the flow of fluid past the valve 30 into the inlet 24. None-
the-less, when pressure is applied from the inlet 24, the cylinder deforms inwardly sufficiently to permit the flow of fluid from the inlet 24 to the mixing chamber 12 between the housing 11 and the outer surface of the valve 30. The nozzle 40 extends away from the mixing chamber 12 and is preferably formed integrally with the housing 11. The nozzle is preferably elongate, as shown, having a length of between 0.5cm and 10cm and an internal diameter of between 0.1mm and 5mm. The device 10 shown in Figures 1 and 2 is formed from a conventional narrow gauge intravenous cannula with an injection port 25 (e.g. 20 or 22G Venflon®). However, the device could, of course, be custom made which would reduce costs. As an example of the spray forming device described above, a carrier gas in the form of medical air or oxygen is supplied from a pressurised canister thereof (not shown) to the device 10 via medical "green bubble tubing" (not shown) which is releasably attached to the gas port means 15. Alternatively, a syringe or part thereof may be releasably attached to the gas port means 15, and the tubing may be releasably attached to the syringe. The gas is supplied to the device 10 at a rate of about 1 to 2 litres per minute.
Simultaneously, a syringe (not shown) containing an agent (e.g. anaesthetic) in the form of a solution or mixture of solutions, is releasably attached to the agent port means 25. The agent is injected around the valve 30 into the mixing chamber 12. Meanwhile, the flow of the pressurised carrier gas through the centre of the valve 30 causes the carrier gas at the downstream side of valve to be turbulent. As a result of the turbulence the agent is essentially atomised and substantially evenly dispersed throughout the carrier gas. The spray thus formed travels along the nozzle 40 to its tip, from which it emerges as a fine, well directed spray.
When all of the required agent has been administered, the device
10 is disposed of and a new device 10 may be used on the next patient. This eliminates the risk of cross-infection between patients as a result of
the continued use of a single spray forming device.
Claims
1. A spray forming device for producing a spray in the form of an atomised agent dispersed within a carrier gas, the device comprising a mixing chamber having a releasable gas port means for attachment to a supply of pressurised carrier gas; a releasable agent port means for attachment to a supply of the agent to be dispersed; and an outlet nozzle.
2. A spray forming device as claimed in claim 1 , further comprising a one-way valve associated with the agent port means, which valve acts to prevent the flow of gas from the mixing chamber towards the supply of agent via the agent port means.
3. A spray forming device as claimed in claim 2 wherein said valve takes the form of a flexible sleeve mounted in the mixing chamber such that a part of its outer surface lies against, and thus closes, an inlet from the agent port means.
4. A spray forming device as claimed in claim 3 wherein the mixing chamber has at least a section which is cylindrical in shape, wherein said agent port means is situated in said section, and wherein said flexible sleeve is of cylindrical shape and fits closely within the said section of the mixing chamber, covering the agent port means.
5. A spray forming device as claimed in either one of claims 3 or 4 wherein said sleeve is made of rubber.
6. A spray forming device as claimed in any one of the preceding claims wherein the outlet nozzle is elongate and has a length of between 0.5cm and 10cm and an internal diameter of between 0.1mm and 5mm.
7. A spray application system comprising a spray forming device as claimed in any one of the preceding claims, means for supplying agent to the device, which means is connected to the device via the agent port means, and a source of pressurised carrier gas, which source is connected to the device via the gas port means.
8. A spray application system as claimed in claim 7 wherein said means for supplying agent comprises a syringe.
9. A method of forming a. spray in the form of an atomised agent dispersed within a carrier gas, the method comprising the steps of providing a device comprising a mixing chamber having a releasable gas port means, a releasable agent port means and an outlet nozzle; releasably attaching a pressurised source of carrier gas to the gas port means; releasably attaching a means for supplying agent to the device, to the agent port means; and simultaneously supplying carrier gas and agent to the mixing chamber via the first and second inlets respectively.
10. A method as claimed in claim 9 wherein the carrier gas is a respirable gas such as medical oxygen or air.
11. A method as claimed in either one of claims 9 or 10 wherein the carrier gas is supplied to the mixing chamber at a rate of 1 to 2 litres per minute.
12. A method as claimed in any one of claims 9 to 11 which is carried out in synchrony with a patient's inspiration.
13. A method as claimed in any one of claims 9 to 12 wherein the agent is a drug or anaesthetic.
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GB9709692.9 | 1997-05-13 | ||
| GBGB9709692.9A GB9709692D0 (en) | 1997-05-13 | 1997-05-13 | Spray forming device |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| WO1998051363A1 true WO1998051363A1 (en) | 1998-11-19 |
Family
ID=10812235
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| PCT/GB1998/001341 WO1998051363A1 (en) | 1997-05-13 | 1998-05-11 | Spray forming device |
Country Status (2)
| Country | Link |
|---|---|
| GB (1) | GB9709692D0 (en) |
| WO (1) | WO1998051363A1 (en) |
Cited By (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP0843565A4 (en) * | 1995-05-12 | 2002-10-16 | Genentech Inc | Coarse spray delivery of functional biologic materials |
Citations (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US3416567A (en) * | 1964-02-20 | 1968-12-17 | Viggo Ab | Syringe valve |
| US4537188A (en) * | 1982-01-26 | 1985-08-27 | Senki Medical Instrument Mfg. Co., Ltd. | Gas jet device for use in respirators |
| US5233979A (en) * | 1990-10-22 | 1993-08-10 | Ballard Medical Products | Methods and apparatus for a micro-tracheal catheter hub assembly |
| US5388571A (en) * | 1987-07-17 | 1995-02-14 | Roberts; Josephine A. | Positive-pressure ventilator system with controlled access for nebulizer component servicing |
| EP0642838A2 (en) * | 1993-09-09 | 1995-03-15 | Acheson Industries Deutschland | Spray element |
-
1997
- 1997-05-13 GB GBGB9709692.9A patent/GB9709692D0/en active Pending
-
1998
- 1998-05-11 WO PCT/GB1998/001341 patent/WO1998051363A1/en active Application Filing
Patent Citations (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US3416567A (en) * | 1964-02-20 | 1968-12-17 | Viggo Ab | Syringe valve |
| US4537188A (en) * | 1982-01-26 | 1985-08-27 | Senki Medical Instrument Mfg. Co., Ltd. | Gas jet device for use in respirators |
| US5388571A (en) * | 1987-07-17 | 1995-02-14 | Roberts; Josephine A. | Positive-pressure ventilator system with controlled access for nebulizer component servicing |
| US5233979A (en) * | 1990-10-22 | 1993-08-10 | Ballard Medical Products | Methods and apparatus for a micro-tracheal catheter hub assembly |
| EP0642838A2 (en) * | 1993-09-09 | 1995-03-15 | Acheson Industries Deutschland | Spray element |
Cited By (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP0843565A4 (en) * | 1995-05-12 | 2002-10-16 | Genentech Inc | Coarse spray delivery of functional biologic materials |
Also Published As
| Publication number | Publication date |
|---|---|
| GB9709692D0 (en) | 1997-07-02 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| EP2678055B1 (en) | A device for administering therapeutic substances using a high velocity liquid-gas stream | |
| CN210250131U (en) | Device for applying liquid therapeutic substances to tissue | |
| US5297543A (en) | Medication inhaler mixer | |
| EP0983103B1 (en) | Device for administering a medicinal aerosol via the lungs | |
| US2535844A (en) | Aspirator for administering medicine | |
| JP6156799B2 (en) | Anesthetic inhalation assist device and its attachment | |
| EP0692273B1 (en) | Nebulizing catheter system and method of manufacture | |
| US6085742A (en) | Intrapulmonary delivery device | |
| US8146587B2 (en) | Method for nasal irrigation and drug delivery | |
| US20040084049A1 (en) | Nebulizing catheter system and methods of use and manufacture | |
| US8042536B1 (en) | Nebulizer apparatus | |
| JPS5825466B2 (en) | Liquid volume control method in medical sprayer and medical sprayer | |
| JPH10500035A (en) | Resuscitator | |
| US6237597B1 (en) | Endotracheal medication port adapter | |
| WO2008056986A1 (en) | System for artificial respiration of persons | |
| US20190232031A1 (en) | Methods and systems for bathing nose and sinus passages | |
| AU2003270242A1 (en) | Drug nebulizer usable with a diagnostic or therapeutic instrument, such as a bronchoscope | |
| JP3500151B2 (en) | The endotracheal tube where the aerosol is diverted and supplied at Murphy Eye | |
| CA2908781C (en) | Cpap flow driver for using nebulizer with cpap apparatus | |
| JP3652216B2 (en) | Chemical spray tube | |
| WO1998051363A1 (en) | Spray forming device | |
| EP1364671B1 (en) | Breathing device with nebuliser | |
| JPH0454971A (en) | Aerosol drug administration method | |
| CN211068508U (en) | Medical local atomizing medicine feeder | |
| CN218552854U (en) | Clinical anesthesia is with supplying medicine anesthesia device |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| AK | Designated states |
Kind code of ref document: A1 Designated state(s): CA GB JP US |
|
| AL | Designated countries for regional patents |
Kind code of ref document: A1 Designated state(s): AT BE CH CY DE DK ES FI FR GB GR IE IT LU MC NL PT SE |
|
| 121 | Ep: the epo has been informed by wipo that ep was designated in this application | ||
| NENP | Non-entry into the national phase |
Ref country code: CA |
|
| NENP | Non-entry into the national phase |
Ref country code: JP Ref document number: 1998548909 Format of ref document f/p: F |
|
| 122 | Ep: pct application non-entry in european phase |